Table 2 Extramedullary plasmacytoma cases of nasal and paranasal sinuses reported in the English language literature
Reference | Pt | Age/Sex | Site | Symptoms | Treatment | Recurrence | Mts | Follow-up |
|---|---|---|---|---|---|---|---|---|
Ashraf et al. 2013 [7] | 3 | 43/M | Nasal cavity | Nasal obstruction, epistaxis | RT+surgery Surgery+RT (44 Gy) RT | No No No | No No No | 1 year 1 year 3 years |
Corvo et al. 2013 [13] | 1 | 51/F | Nasal cavity/maxillary sinus | Nasal obstruction, epistaxis | RT (48 Gy)+surgery | No | No | 6 years |
Verim et al. 2014 [10] | 1 | 69/F | Frontal sinus (4×3 cm) | Chronic headache | Surgery+RT (40 Gy) | No | No | 18 months |
D’Aguillo et al. 2014 [8] | 175 | 55/ M:F of 2.3:1 M (69.4%) F (30.6%) | Nasal cavity/septum (32.5%), maxillary sinus (26.8%), nasopharynx (18.6%), ethmoid sinus (7.2%), sphenoid sinus (6.7%), paranasal sinus (6.2%), frontal sinus (2.1%) | Nasal obstruction (29.8%), epistaxis (24.2%), facial swelling (9.9%), facial pain (9.9%), painless mass (6.8%), change or loss of vision (6.2%), nasal discharge (4.3%), CN VI palsy (3.7%), proptosis/ptosis (2.5%), headache (2.5%) | RT (50.9%), surgery+RT (21.7%), surgery (14.3%), CHT (1.7%), RT+CHT (5.1%), RT+Surgery+CHT (3.4%), no therapy (2.9%) | 16% | No | 39–60.9 months |